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Education is not the learning of facts
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Albert Einstein
4ABSTRACT
Acute otitis media (AOM) is an infection that is particularly common in children. Th e bacterial 
etiology of AOM, in both children and adults, aff ects its clinical picture. While in some cases 
the infection can simply be carefully monitored without treatment, antimicrobials are oft en 
prescribed. Caution is required, however, when prescribing antimicrobials as their excessive use 
has led to antimicrobial resistance; this resistance has been seen among some of the causative 
pathogens for these infections. 
Before the development of antimicrobial treatment, complications due to middle ear infections 
were common, potentially causing severe symptoms or even death. Some middle ear infections 
spread into surrounding structures, leading to intratemporal or extratemporal (extracranial or 
intracranial) complications. Th is thesis focuses on complicated otitis media and the causative 
factors of its complications.
In the fi rst two studies, we evaluated the medical records of all (n=100) children (0-16 years 
old) hospitalized at the Department of Otorhinolaryngology in the Helsinki University Hospital 
from 2003 to 2012 for acute mastoiditis (AM) or AOM, as well as the infection’s bacteriology 
in relation to the patient’s clinical fi ndings and treatment. Using this information, we analyzed 
the diff erences in the etiologies and clinical pictures of those children hospitalized due to AOM 
compared to AM.  
In our third study, we examined the medical records of all (n=166) patients hospitalized at our 
institution from 1970 to 2012 due to intracranial abscesses (IA), including those of otogenic 
background (oIA).
In the fourth study, we evaluated the bacteriology in relation to the patients’ clinical fi ndings 
and treatment in all (n=160) adult patients treated at our institution from 2003 to 2012 for AOM 
or acute mastoid infection. In adults, acute mastoid infection was subclassifi ed into AM, latent 
mastoiditis (LM), and AM following chronic middle ear infection (AMc).  
Th e clinical picture of AM in children diff ered according to the causative pathogen. Streptococcus 
pneumoniae (Pnc), especially its resistant strains, caused severe symptoms and oft en led to 
mastoidectomies. Pseudomonas aeruginosa (Ps) typically aff ected older children with prior 
tympanostomy tubes and generally caused milder symptoms. Furthermore, the bacteriological 
etiology of hospitalized AOM and AM patients was diff erent compared to outpatient AOM. Two 
of the typical AOM pathogens, Haemophilus infl uenzae (Hi) and Moraxella catarrhalis (Mc), 
were uncommon among the hospitalized patients. Pnc, especially its resistant strains, was less 
common in children hospitalized for AOM compared to AM, and less common in adults than 
children. Streptococcus pyogenes (StrA) and Ps were both linked to otorrhea and were found only 
in older children. 
Over our 42 year study period, oIAs became less common and typically developed following 
chronic middle ear infections, oft en in connection with cholesteatoma. 
5In adults, the bacteriological etiology and clinical picture of AMc diff ered from AOM as well as 
the other acute mastoid infection types (AM, LM). AOM and AM led to less surgical procedures 
than the more prolonged forms of acute mastoid infection (LM, AMc).  
In children, the hospitalized cases of AOM and AM diff ered from outpatient AOM. In adults, 
severe AOM, AM, and LM seem to compose a continuum that may lead to chronic otitis media 
and its acute complications, including oIAs. Otogenic IAs are quite rare, however, and became 
less common over our study period.
6 TIIVISTELMÄ
Äkillinen välikorvatulehdus on yksi lasten tavallisimmista taudeista; aikuisilla se on lapsia 
harvinaisempi. Vaikka pelkkä seuranta voi riittää äkillisen välikorvatulehduksen hoidoksi, usein 
hoitona käytetään antibioottia. Välikorvatulehdus voi levitä välikorvaa ympäröiviin rakenteisiin 
aiheuttaen vakaviakin komplikaatioita (esim. kartiolisäketulehdus, aivopaise). Ennen 
antibioottien kehittämistä välikorvatulehduksen komplikaatioita esiintyi nykyistä enemmän. 
Turhaa antibioottien käyttöä on vältettävä, mutta komplisoitunutta tautia sairastavat potilaat on 
tunnistettava varhain ja hoidettava tehokkaasti. Tässä tutkimuksessa selvitettiin komplisoituneen 
välikorvatulehduksen taustatekijöitä.
Äkillisen kartiolisäketulehduksen tai välikorvatulehduksen vuoksi HUS:n Korvaklinikalle 
sairaalahoitoon vuosina 2003–2012 joutuneiden potilaiden (100 lasta, 160 aikuista) 
sairauskertomustiedot käytiin läpi. Bakteereiden suhdetta taudinkuvaan ja hoitoon arvioitiin, 
ja potilasryhmien tietoja vertailtiin keskenään. Kaikkien aivopaiseen vuoksi sairaalahoitoon 
HUS:n Neurokirurgian klinikalle vuosina 1970–2012 joutuneiden potilaiden (166) 
sairauskertomustiedot käytiin läpi. Aineistoon sisältyivät myös korvaperäiset aivopaiseet.
Streptococcus pneumoniae on tavallinen välikorvatulehduksen taudinaiheuttaja, myös tässä 
tutkimuksessa. Erityisesti kartiolisäketulehdusta sairastavilla lapsipotilailla esiintyi muita 
lapsia ja aikuisia enemmän tavallisille korvatulehduksen hoidossa käytettäville antibiooteille 
vastustuskykyisiä Streptococcus pneumoniae -kantoja. Nämä johtivat muita taudinaiheuttajia 
useammin kartiolisäkkeen puhdistusleikkauksiin. Kaksi tavallisimmista äkillisen 
välikorvatulehduksen taudinaiheuttajista, Haemophilus infl uenzae ja Moraxella catarrhalis, olivat 
sen sijaan harvinaisia komplisoitunutta välikorvatulehdusta sairastavilla potilailla. Aikuisilla 
pitkäkestoisten välikorvatulehdusten äkillisiin komplikaatioihin liittyi enemmän leikkaushoidon 
tarvetta kuin äkillisten välikorvatulehdusten komplikaatioihin. Korvaperäiset aivopaiseet 
harvinaistuivat ajan kuluessa, ja ne liittyivät yleensä pitkäkestoiseen välikorvatulehdukseen ja 
helmiäiskasvamaan. 
Avohoidossa hoidettava välikorvatulehdus eroaa sairaalahoitoon johtaneesta 
välikorvatulehduksesta ja kartiolisäketulehduksesta. Välikorvatulehduksen komplikaatiot 
voivat johtaa pitkäkestoiseen välikorvatulehdukseen ja sen akuutteihin komplikaatioihin, myös 
aivopaiseisiin. Korvaperäiset aivopaiseet olivat tutkimusaineistossa kuitenkin harvinaisia, ja 
niiden määrä vähentyi tutkimusjakson kuluessa.
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ABBREVIATIONS
AM  acute mastoiditis
AMc  acute mastoiditis in a patient with CSOM
AOM  acute otitis media
CSOM  chronic suppurative otitis media
CRP  C-reactive protein (mg/l)
CT  computed tomography
EAC  external auditory canal
ENT  ear, nose, and throat
ET  Eustachian tube
Hi  Haemophilus infl uenzae (non-encapsulated)
IA  intracranial abscess
ICD-9  international classifi cation of diseases, version 9
ICD-10   international classifi cation of diseases, version 10
LM   latent mastoiditis
Mc  Moraxella catarrhalis
MEE  middle ear eff usion
MIC  minimal inhibitory concentration (mg/l)
MRI  magnetic resonance imaging
oIA  otogenic intracranial abscess
OM  otitis media
OME  otitis media with eff usion
PCV  pneumococcal conjugate vaccine
Pnc  Streptococcus pneumoniae
Ps  Pseudomonas aeruginosa
Sa  Staphylococcus aureus
StrA  Streptococcus pyogenes
TM  tympanic membrane
URTI  upper respiratory tract infections
WBC  leukocyte count (E9/l)
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1  INTRODUCTION
Acute otitis media (AOM), infection of the middle ear, is one of the most common infections 
in children, though it aff ects adults as well. Middle ear infections, and the problems caused by 
them, however, diff er between children and adults. Children are prone to developing AOM due 
to anatomical and immunological immaturity, whereas adult ear infections are typically chronic 
in nature (Bluestone 2008). AOM is treated with antimicrobials, or in some cases by expectant 
observation.
Viral upper respiratory tract infections (URTI) oft en precede bacterial AOM, especially 
in children. Th e AOM-causing bacteria typically originate from the nasopharynx via the 
Eustachian tube (ET). AOM caused by Streptococcus pneumoniae (Pnc) has been associated with 
a severe form of the infection, with fever and earache, while AOM caused by non-encapsulated 
Haemophilus infl uenzae (Hi) has been associated with conjunctivitis (Palmu et al. 2004). Hi and 
Moraxella catarrhalis (Mc) rarely cause complications, whereas Streptococcus pyogenes (StrA) has 
been associated with complicated AOM (Segal 2005). In prolonged middle ear infections, middle 
ear mucosa swells, resulting in hypoxemia and metabolic changes which leads to the selection of 
pathogens that survive in these conditions. 
Tympanic membrane (TM) perforations and bone erosions may allow for the spreading of 
infection to and from the middle ear, allowing for complications to arise. Complications of 
otitis media (OM) can be classifi ed into intratemporal and extratemporal (either intracranial 
or extracranial). Anatomical or immunological conditions may predispose patients to these 
complications. Th e thinner bony structures of children may more easily be resorbed by infection, 
allowing for easier development of AOM complications (Stenfeldt et al. 2014).  
Before the development of antimicrobial treatment, complications of OM were common and 
caused severe morbidity, and even death (Valentine 1924, Palva et al. 1959). Complications due 
to OM have since become uncommon, but have not completely disappeared. Furthermore, the 
clinical picture of complications has changed with antimicrobial treatment potentially masking 
symptoms and leading to a prolonged, mild form of disease (Faye-Lund 1989). 
Complications of OM can develop following untreated or incompletely treated infections as well as 
cases with adequate antimicrobial treatment, and are also seen with infections caused by bacteria 
that are resistant to antibiotics (Zapalak et al. 2002). Antimicrobial resistance of pathogens has 
developed due to the excessive use of antibiotics. While patients with severe infections, or those 
at risk of developing complications, should be eff ectively treated, antimicrobial treatment may be 
unnecessary in patients with only mild infection.  
We need to better understand which patients require antimicrobial treatment to achieve a 
successful recovery, and which patient’s infections will resolve themselves - to be able to do this, 
we must study complicated cases of OM; this study aims to do that.     
Introduction
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2 REVIEW OF THE LITERATURE
2.1 Historical aspects
“Acute pain of the ear, with continual and strong fever, is to be dreaded; for there is 
danger that the man may become delirious and die. Since, then, this is a hazardous spot, 
one ought to pay particular attention to all these symptoms from the commencement. 
Younger persons die of this disease on the seventh day, or still earlier, but old persons 
much later; for the fevers and delirium less frequently supervene upon them, and on 
that account the ears previously come to a suppuration, but at these periods of life, 
relapses of the disease coming on generally prove fatal. Younger persons die before 
the ear suppurates; only if white matter run from the ear, there may be hope that a 
younger person will recover, provided any other favorable symptom be combined” 
(Hippocrates, 400 BC).
Despite the immense advancements in medicine since Hippocrates’ time, his description 
of complicated OM does not sound outdated to a modern otorhinolaryngologist. Not only 
have the knowledge of anatomy and the understanding of the disease’s underlying conditions 
advanced since his time, but fairly recent great developments have been made in the diagnostics, 
and treatment of diseases. While living in the age of antimicrobials means we are oft en able to 
prevent the most severe complications that Hippocrates saw, we still see patients, young and old, 
presenting with OM and its complications.  
Before the late 1800s, intracranial abscesses (IA) almost always led to death (Mathisen et al. 
1997). Th en antimicrobials arrived, with sulfonamides being introduced in the 1930s and 
penicillin, streptomycin, chloramphenicol, and tetracyclins all being introduced in the 1940s 
(Simpson 2013). Before antibiotics, complications due to OM were diffi  cult to treat, with StrA 
being the most common pathogen that led to AOM complications (Valentine 1924, Palva et al. 
1959, Vergison 2008).    
In less than 100 years since their introduction, however, the eff ectiveness of antimicrobials has 
been reduced. Currently, bacterial resistance to antimicrobials is a growing global problem due, 
in large part, to the oft en excessive use of antibiotics in the human medical fi eld as well as in agri- 
and aquaculture (Silbergeld et al. 2008, Heuer et al. 2009).  
Th ankfully, tools to aid in the diagnostics and treatment of OM and its complications have been 
developed. Computed tomography (CT) imaging was introduced in the 1970s (Simpson 2013), 
and magnetic resonance imaging (MRI) was utilized in clinical practice starting in the early 
1980s (Ai et al. 2012).  
Review of the Literature
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Review of the Literature
2.1 Anatomy 
The ear and temporal bone
Th e outer ear consists of the pinna (auricula) and the external auditory canal (EAC). At the end 
of the EAC lies the TM, which forms the lateral border of the middle ear (Figure 1). 
Th e middle ear is an air-fi lled cavity lined by mucous membrane; situated inside the temporal 
bone it consists of the squamous, petrous, mastoid, tympanic, and styloid bones (Figure 2). 
Th e uppermost part of the middle ear, the epitympanum or atticus, is superior to the TM. Th e 
structure of the TM’s superior portion (pars fl accida, Schrapnell’s membrane) is less robust than 
that of the main part (pars tensa). Negative pressure in the middle ear may lead to retractions 
and perforations of the pars fl accida.
Th e middle ear connects to the nasopharynx by the ET, which helps in pressurizing the middle 
ear and in removing middle ear secretion. Th e ET is shorter, soft er, and has a more horizontal 
course in children than adults. Running medially to the ET is the internal carotid artery.
Th e auditory ossicles - malleus, incus, and stapes - form a chain with the malleus attaching to the 
TM in the umbo, while the stapes footplate is situated over the oval window. Th e whole chain is 
attached to the roof of the middle ear via ligaments connected to the malleus and incus. Blood 
supply to the middle ear mainly comes from branches of the internal maxillary artery. Infections 
may cause bone resorption of the auditory ossicles, which may cause hearing problems. Th e 
middle ear is inferiorly separated from the bulbus of the internal jugular vein by only a thin layer 
of bone; if this bone is resorbed, an infectious thrombus may result.
Th e bony labyrinth consists of the cochlea, the vestibule, and the semicircular canals (Figure 1). 
Th e membranous labyrinth, fi lled with endolymph, fl oats inside the bony labyrinth surrounded 
by perilymph. Th ese structures are involved in the sense of balance and hearing. Th e vestibule 
connects to the saccus endolymphaticus situated within the dura mater. Th e vestibule connects to 
the middle ear via the oval and round windows, while the cochlea connects to the subarachnoid 
space via a cochlear aqueduct. Th e sensory organ of hearing, the organ of Corti, is situated within 
the cochlea. Intracranial spreading of a middle ear infection may occur through the middle 
cranial fossa bone at the roof of the middle ear (tegmen tympani), as well as through the saccus 
endolymphaticus or the cochlear aqueduct. 
Th e facial nerve travels through the internal acoustic meatus, along with the cochlear and 
vestibular nerves. Th e facial nerve can be divided into sections: the meatal segment, the 
labyrinthine segment, the tympanic segment, the mastoid segment, and the extratemporal 
segment. Th e facial nerve may become infected if the bone covering it becomes dehiscent or 
resorbed. 
14
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Figure 1.  Anatomy of the ear (images by, and modifi ed by, Helena Schmidt; from Laulajainen-
Hongisto et al. 2012, with permission of Duodecim)
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Th e inner and middle ear structures develop before birth. Th e mastoid process, however, is 
close to nonexistent in neonates and the position of the entire temporal bone is inferolateral 
compared to adults. Due to the neonatal absence of the mastoid process, the facial nerve 
exits the stylomastoid foramen on the lateral aspect of the skull, and, thus, is prone to injury 
during operative treatment in young children. While the antrum is already present in infants, 
and connects to the upper part of the middle ear through the aditus ad antrum, mastoid 
pneumatization is not completed at birth. Air-fi lled cells, covered by mucous membrane, develop 
as the bony structures are pneumatized, with the degree of pneumatization being aff ected by 
middle ear ventilation, hereditary, environmental, nutritional, and infectious factors (Palva 1991, 
Glasscock & Shambaugh 1990, Cinamon 2009).  
Review of the Literature
Figure 2.  Th e temporal bone and its surrounding structures (by Helena Schmidt)
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The brain and intracranial space in rela? on to the ear
Th e roof of the middle ear, the tegmen tympani, is situated under the brain. Th e middle ear and 
the brain are separated by mucous membrane, periosteum, bone, and the meninges. Th ree layers 
of meninges surround the brain: the dura mater, the pia mater, and the arachnoid mater. Th e 
resulting epidural, subdural, and subarachnoid spaces are seen in Figure 3.
Th e cerebrum is situated above the tentorium cerebelli and it can be divided into temporal, 
occipital, parietal, and frontal lobes. Th e cerebellum is located under the tentorium cerebelli. 
Th e pons and the brain stem are located anterior to the cerebellum. Th e brain’s ventricular 
system comprises four interconnected ventricles: two lateral ventricles and the third and fourth 
ventricles. Th e fourth ventricle continues into the spinal cord.
Th e brain receives arterial blood from the internal carotid artery and the vertebral arteries. 
Th e choroid plexuses of the lateral ventricles produce cerebrospinal fl uid from arterial blood; 
this fl uid fl ows in the ventricular system and is gradually absorbed by the arachnoid villi of the 
subarachnoid space (Purves et al. 2001). Dural venous sinuses (two sigmoid sinuses on either 
side of the head, the transverse sinus connecting these two, and the superior sagittal sinus 
extending superiorly) receive this absorbed cerebrospinal fl uid, as well as blood from the veins 
of the brain. Th e dural venous sinuses empty into the internal jugular veins. Additionally, venous 
blood from extracranial structures may pass through the skull bone via emissary veins into the 
dural venous sinuses.
Figure 3.  Th e brain and meninges in relation to the mastoid air cells (image by Helena Schmidt; from 
Laulajainen-Hongisto et al. 2012, with permission of Duodecim)
Review of the Literature
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2.3 O? ? s media
De? ni? on, epidemiology and risk factors
Otitis media is an infl ammation of the middle ear with AOM being an acute infl ammation of the 
middle ear. Th e diagnosis of AOM should be based on acute symptoms, presence of middle ear 
eff usion (MEE), and signs of acute middle ear infl ammation with a bulging of the TM (Lieberthal 
et al. 2013). AOM is a common infection in children; by the age of three, 83% have had at least 
one episode of AOM (Teele et al. 1989). On average, children experience fi ve URTI episodes and 
two AOM episodes per child-year during their fi rst three years of life (Chonmaintree et al. 2008). 
Some children suff er from glue ear (otitis media with eff usion, OME) or recurrent AOM. OME 
has been defi ned as infl ammation of the middle ear with MEE, but without signs and symptoms 
of infection; while recurrent AOM is defi ned as three or more documented, separate episodes 
of AOM in the preceding six months, or four or more episodes in the preceding 12 months, 
with at least one episode within the last six months (Lieberthal et al. 2013).  OME and recurrent 
AOM may lead to surgical interventions. A prolonged middle ear infection may lead to the 
development of chronic suppurative otitis media (CSOM), which is defi ned as purulent otorrhea 
persisting for more than 6 weeks in a patient with a chronic TM perforation (Gould et al. 2010).  
Although problems caused by AOM predominate in the pediatric population, middle ear 
infections also aff ect adults. Th e problems in children, however, are not the same in adults. 
Adults have more prolonged ear problems, CSOM, and cholesteatoma than children. CSOM 
and cholesteatoma have become less common over time in Finland, probably due to the more 
effi  cient treatment of AOM (Alho et al. 1997). Th e annual incidence of cholesteatoma in Finland 
was 9/100,000 in 1982-1991 (Kemppainen et al. 1999). 
In Finland, 500,000 episodes of AOM occur annually (Niemelä et al. 1999). Globally, 709 million 
cases of AOM occur annually, 51% of these in children under the age of fi ve (Monasta et al. 
2012). Additionally, 31 million cases of CSOM occur annually, of which 23% are children under 
the age of fi ve (Monasta et al. 2012). CSOM is uncommon in developed countries compared 
to developing ones. Th e prevalence and severity of both acute and chronic OM in developing 
countries is higher, along with deafness and severe suppurative complications (Bluestone 1998, 
Vergison et al. 2010, Monasta et al. 2012).  
AOM reduces the quality of life for children and their parents, and recurrent AOM may even 
delay a child’s language development. AOM also burdens society through the cost of the medical 
treatment for AOM, the use of medical care facilities, as well as loss of productivity due to 
parental absence from work (Greenberg et al. 2003, Brouwer et al. 2005, Arguedas et al. 2010, 
Haapala et al. 2014). 
Children are prone to develop AOM due to anatomical factors (position of ET) and their under 
developed immune system (Bluestone 2008). Innate immunity is already functioning at birth, 
whereas adaptive immunity develops as pathogens are encountered (Mittal et al. 2014a). 
OM is a multifactorial disease; environmental, bacteriological, host, immunological, and genetic 
factors aff ect its development (Rye et al. 2012). From twin and family studies, we know that 
genetic factors play a major part in susceptibility to OM with heritability being approximately 
40-70%   (Hafrén et al. 2012, Mittal et al. 2014a). A family history of AOM is a risk factor for 
Review of the Literature
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development of AOM in a child (McCormick et al. 2011). Ciliary dysfunction, cleft  palate, 
craniofacial anomalies, and Down syndrome are additional known risk factors for AOM (Gould 
et al. 2010). 
As with AOM, CSOM is also a multifactorial disease (Bluestone 1998, Mittal et al. 2015). 
Susceptibility to OM may, in adults, be aff ected by how well an individuals (innate) immunity 
functions (Mittal et al. 2014b). Since CSOM is preceded by AOM or OME, prevention of the 
earlier infections can reduce the cases of CSOM (Bluestone 1998). 
Children who experience their fi rst AOM before the age of six months are more prone to 
additional AOM infections later in childhood (Gould et al. 2010). Th e amount of contacts with 
other children (leading to increased exposure to viruses and bacteria) is a risk factor for the 
development of AOM. Children with siblings and those in day-care have more AOM than others 
(OR=1.8 for children in day care to become otitis-prone with ≥3 episodes of AOM) (Alho et 
al. 1990, Uhari et al. 1996). Passive smoking and the use of a pacifi er are additional risk factors 
for AOM (Etzel et al. 1992, Uhari et al. 1996, Warren et al. 2001). Passive smoking is also a risk 
factor for recurrent AOM aft er tympanostomy tube insertion (Hammarén-Malmi et al. 2007). 
Th e presence of these risk factors, such as passive smoking and family history of AOM, are also 
associated with a more severe clinical picture (McCormick et al. 2011). Breast-feeding for at least 
three months, on the other hand, reduces the risk of AOM (Uhari et al. 1996). 
E? opathogenesis
AOM oft en develops as a complication of viral URTI. Many viruses can cause URTI: rhino-, 
corona-, adeno-, entero-, and infl uenza viruses. Th e respiratory syncytial virus in particular has 
been associated with AOM (Heikkinen et al. 1999). Viruses alone can cause acute middle ear 
infection, but the interplay of viruses with bacteria is important in the development of AOM, 
with the resulting AOM being a combination of a viral and bacterial infection (Chonmaitree et 
al. 2008, Marom et al. 2012, Nokso-Koivisto et al. 2015). 
Viral URTI results in infl ammatory responses of the nasopharynx and ET, as well as an increased 
bacterial colonization of the nasopharynx. ET dysfunction leads to negative pressure in the 
middle ear, allowing bacteria and viruses to enter, which causes infl ammatory changes in the 
middle ear mucosa resulting in accumulation of MEE. Additionally, the mucous membrane 
lining the mastoid air cells may become infl amed, swollen, and produce mucous secretion. 
In some cases, a middle ear infection may continue despite antimicrobial treatment. Prolonged 
infl ammation results in infl ammatory changes in the middle ear and its surrounding structures 
(Palva et al. 1985). In OME, prolonged AOM leads to negative pressure in the middle ear, 
trapping sterile MEE (Bluestone 1998). Middle ear infections may become chronic, and result 
in CSOM or chronic mastoiditis. ET dysfunction and TM perforation are common mechanisms 
for developing CSOM. Chronic infection and ET dysfunction may result in negative pressure in 
the middle ear, creating conditions for the weaker part of the TM, the pars fl accida, to become 
retracted and perforated. 
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Keratinizing stratifi ed squamous epithelium may start to grow into the middle ear through a 
TM perforation and accumulate in the middle ear or temporal bone, forming a cholesteatoma. 
Most cholesteatomas are situated in the atticus and are acquired. Only 2% are congenital and 
are thought to develop from epithelial rests of the middle ear. Cholesteatoma may erode bone, 
become infected, and cause serious complications (Juliano et al. 2013, Prasad et al. 2013). 
Additionally, a TM perforation may allow a bacterial infection to spread into the middle ear 
from the EAC or from the nasopharynx through the ET, and lead to otorrhea. 
In patients with CSOM, hearing loss may result from chronic MEE, as well as from bone erosion 
leading to disruptions in the auditory ossicles.
Bacteriology 
Th e most common bacterial pathogens of AOM in children are Pnc (23%-26%), Mc (18%-23%), 
and Hi (16%-23%) (Virolainen et al. 1994, Kilpi et al. 2001, Palmu et al. 2004), while the most 
common pathogens of AOM in adults are Hi (26%), Pnc (21%), and StrA (4%) (Celin et al. 1991, 
Bluestone et al. 1992) (Figure 4). Th e bacteriological etiology of AOM changes over time and 
is aff ected by environmental factors, vaccinations, and development of antimicrobial resistance; 
these changes must be monitored, especially since the introduction of PCV vaccinations 
(Vergison 2008, Jalava 2014).
Th e bacterial etiology of AOM aff ects its clinical picture. For example, Pnc causes severe 
symptoms with fever, earache, and clear signs of infection of the TM (Rodriguez et al. 1999, 
Palmu et al. 2004). It is reported to be the major pathogen present in 70% of infants with AM 
(Stenfeldt et al. 2014), and is a common pathogen involved in complicated AOM. Th ere is an 
increasing trend of multi-drug resistant Pnc strains among complicated cases of AOM, which 
may result in an overall rise in the number of AOM complications (Antonelli et al. 1999, Zapalac 
et al. 2002, Mattos et al. 2014). Additionally, seasonal variation in penicillin susceptibility of Pnc 
isolates has been reported, with more nonsusceptible strains seen as the winter months progress, 
resulting in potential seasonal variation in the number of OM complications (Hoberman et al. 
2005). In Finland, in 2014, Pnc resistance to penicillin was detected in the pus samples of 12% 
of ≥ 5-year-olds and in 9% of < 5-year-olds, whereas in 2010-2011, 20% of Pnc were resistant to 
penicillin. In 2014, Pnc resistance to trimethoprim-sulfonamide was 10%, whereas in 2009, up to 
30% of Pnc were resistant to trimethoprim-sulfonamide. Pnc resistance to macrolides is reported 
to be 14-27% (Jalava 2014). 
Non-encapsulated Hi is a major pathogen of AOM and is associated with older age, recurrent 
AOM, and bilateral AOM, but not with severe complications (Leibovitz et al. 2004, Segal 2005, 
McCormick et al. 2007, Pichichero et al. 2008. Casey et al. 2010). Due to its relatively low 
virulence, Mc is not common in complications of AOM and seldom causes AM (Leskinen & Jero 
2003, Segal 2005). Some Hi, and almost all Mc, produce beta-lactamase, and thus have natural 
resistance to penicillin and amoxicillin. Th is resistance can, however, be compensated for by the 
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addition of a beta-lactamase-inhibitor, clavulanic acid for example (Jalava 2014). Hi are resistant 
to trimethoprim-sulfonamide in 30% of cases, and almost all Hi are intrinsically resistant to 
macrolides (Leibovitz et al. 2004, Jalava 2014). 
StrA is more common in older than younger children, and has been associated with complicated 
infections, TM perforations, and mastoiditis (Katz et al. 2003, Segal 2005, Shulman et al. 2005).
As in other chronic infections, bacteria involved in CSOM infection may form biofi lms that are 
resistant to treatment (Lampikoski et al. 2012). Pseudomonas aeruginosa (Ps) and Staphylococcus 
aureus (Sa) are common pathogens involved in CSOM, though Proteus vulgaris, Klebsiella 
pneumoniae, Enterobacteriaceae, and anaerobes are also found in this group of patients (Brook 
2005, Yeo et al. 2007, Mittal et al. 2015). Especially in children with prior recurrent AOM, Ps may 
cause AM (Butbul-Aviel et al. 2003). Fucobacterium necroforum is a rare pathogen of complicated 
AOM, that may lead to Lemierre’s syndrome with internal jugular vein thrombosis and septic 
emboli (Gorphe et al. 2011, Wright et al. 2015).   
Vaccina? ons 
Vaccinations are hoped to reduce the burden caused by AOM, especially in developing countries 
with less advanced health care facilities (Vergison et al. 2010). Infl uenza vaccinations have been 
shown to prevent seasonal infl uenza and associated AOM (Block et al. 2011, Heikkinen et al. 
2013). While AOM is sometimes caused by Hi, the Hi type b vaccinations do not protect against 
it because AOM-causing strains are non-encapsulated (nontypable) (Leibovitz et al. 2004).
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Figure 4.  Pathogens of children with outpatient AOM (n=1819 AOM events) (Palmu et al. 2004) and 
pathogens of adults with outpatient AOM (n=34 AOM events) (Celin et al. 1991).
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Pneumococcal conjugate vaccines (PCVs) reduce AOM episodes by 6% and the risk of 
tympanostomy tube insertion in children (between ages 2 to 5) by 34% (Eskola et al. 2001, 
Poehling et al. 2007, Sarasoja et al. 2013). PCVs are also eff ective against invasive pneumococcal 
disease (Whitney et al. 2003, Palmu et al. 2013). Replacement of Pnc with other pathogens or 
non-vaccination serotype Pnc, however, must be monitored (Hicks et al. 2007). Certain Pnc 
serotypes may cause severe infections due to their virulence (e.g. 19A, not included in the 7 
valent PCV), and some have a tendency to develop antimicrobial resistance (e.g. 19A and 35B, 
which is included in the 13 valent PCV) (Hoberman et al. 2011b, Martin et al. 2014). Increased 
antimicrobial resistance of Pnc has been reported aft er onset of pneumococcal vaccinations 
(Farrell et al. 2007). Replacement of Pnc by these non-vaccination Pnc serotypes, may cause 
more acute mastoiditis (Halgrimson et al. 2013, Koutouzis et al. 2016).  
A large US insurance claims database study suggests that the incidence of AM has decreased 
following the introduction of PCVs (Marom et al. 2014), however, several other studies found no 
decrease in AM incidence aft er PCV introduction (Roddy et al. 2007, Leibovitz 2008, Choi et al. 
2011, Daniel et al. 2013, Kordeluk et al. 2015). 
Figure 5.  Th e tympanic membranes of a healthy patient (A) and of a patient with acute otitis media 
(B). © David P. McCormick, M.D., UTMB, with permission.
Diagnos? cs and treatment
Patients with AOM oft en present with symptoms of URTI, earache, and fever. Th e diagnosis of 
AOM cannot, however, rely solely on symptoms.
In the current Finnish guideline for treatment of AOM, the diagnosis of AOM is based on acute 
symptoms of URTI, MEE, and impaired or absent mobility of the TM, or otorrhea (Heikkinen 
et al. 2010). Th e fact that MEE can be a sign of OME, for which no antimicrobial treatment 
is needed, or of AOM, is a diagnostic challenge. Pneumatic otoscopy and tympanometry are 
important tools for detecting MEE. A healthy TM is translucent and pearl gray in color (Figure 
5A). Changes in the translucency (from translucent to semiopaque or opaque) or color (from 
gray to yellow, white, or red) of the TM are used to evaluate patients with AOM, however, a 
bulging of the TM, in particular, has been found to be an important sign of AOM (Lieberthal 
et al. 2013) (Figure 5B). Th e current clinical practice guideline from the American Academy of 
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Pediatrics advises that the diagnosis of AOM should be based on acute symptoms, the presence 
of MEE, and signs of acute middle ear infl ammation, especially with a bulging of the TM, to 
diff erentiate between MEE caused by OME and AOM (Lieberthal et al. 2013).  AOM causes 
otorrhea in children with prior tympanostomy tubes, however, a spontaneous perforation of the 
TM can be a sign of severe AOM. 
Since decisions regarding surgeries for AOM are based on the number of AOM episodes in 
individual patients, wrong diagnoses may lead to unnecessary tympanostomies and adenotomies. 
Repetitive antimicrobial treatments may lead to the development of resistant pathogens, and 
may cause adverse events (vomiting, diarrhea, rash, allergic reactions) (Venekamp et al. 2013). 
Antimicrobial treatment also has eff ects on the intestinal microbiome, which may be associated 
later in life with obesity (Saari et al. 2015). 
Spontaneous resolution of AOM without antimicrobial treatment is common and occurs in 
80% of patients within 2-3 days (Rosenfeld et al. 2003, Stevanovic et al. 2010, Venekamp et al. 
2013). Antimicrobial treatment reduces the duration of MEE by two weeks and patients treated 
with antimicrobials also have less persistent MEE (5% vs. 24% in placebo group), and less 
resulting hearing impairment (Tapiainen et al. 2014). So called wait-and-see prescriptions of 
antimicrobials have been shown to reduce their unnecessary use (Spiro et al. 2006).
Patients with bilateral AOM are more likely to have persistent symptoms if not treated with 
antimicrobials, are more likely to have bacteria in the MEE, and are younger (McCormick et 
al. 2007). Children under the age of two benefi t from antimicrobial treatment of AOM by a 
reduction of symptom burden, and shorter times to symptom resolution (Klein 2011, Tähtinen 
et al. 2011, Hoberman et al. 2011a, Hoberman et al. 2013). Th e expectant observational approach 
is accepted for most older children with mild disease in high-income countries (Venekamp et al. 
2013).
National diff erences are seen in the prescription rates of antimicrobial treatment; in the 
Netherlands, antimicrobial treatment is given to 31% of patients with AOM, whereas in most 
other western countries, over 90% of patients with AOM receive antimicrobial treatment 
(Schilder et al. 2004). In Sweden, no increase in the incidence of AM in children has been 
reported following the introduction of watchful waiting as an alternative treatment for AOM 
(Stenfeldt et al. 2010, Groth et al. 2011). Antimicrobial treatment halves the risk of mastoiditis; 
the number needed to treat AOM to avoid one case of AM, however, is high (approximately 
4,800) (Petersen et al. 2007, Th ompson et al. 2009). 
Pain medication is an important part of AOM treatment. Oral prednisolone has been shown 
to be modestly eff ective as an adjuvant treatment of AOM with tympanostomy tube otorrhea 
(Ruohola et al. 1999). Th is study alone, however, does not indicate regular use of steroids for 
AOM. On the other hand, steroids have been proven effi  cient in other otological conditions such 
as labyrinthitis and Bell’s palsy, and since they reduce tissue swelling, they are oft en used to treat 
complicated OM (Hartnick et al. 2001, Salinas et al. 2010). 
Th e treatment recommendations for AOM in Finnish current care guidelines have changed 
over time. Much more active treatment was recommended in the 1970s than currently (Palva 
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et al. 1973, Puhakka et al. 1999, Heikkinen et al. 2010). Th ese changes have most likely aff ected 
our results, especially regarding otogenic intracranial abscesses. Currently, the following 
treatment of AOM is recommended: adequate treatment of pain in all patients, antimicrobial 
treatment (primarily with amoxicillin or penicillin) in most patients with a clear diagnosis of 
AOM (especially in children under the age of two, in patients with bilateral infection, and in 
patients with otorrhea), and the possibility of expectant observation with follow-up in 2-3 days 
(Heikkinen et al. 2010).
Tympanostomy tubes reduce the risk of recurrent AOM by 1.5 episodes of AOM in the 6 months 
following tube insertion (Gebhart 1981, McDonald et al. 2011, Kujala et al. 2012). Adenotomy 
is benefi cial in removing MEE, but has no additional value compared to tympanostomy tube 
placement in reducing episodes of AOM (van den Aardweg et al. 2010, Kujala et al. 2012). 
Tympanostomy tubes can also treat OME, having a benefi cial eff ect on hearing for 6 months 
in children with prolonged OME (>12 weeks) and hearing loss (Browning et al. 2010). It is 
important to note, however, that tympanostomy tubes may lead to TM perforations, occurring 
more oft en with longterm (several years) than short term (8-14 months) tympanostomy 
tubes (17% vs. 2%, respectively) (Kay et al. 2001). TM perforations may lead to the need for 
further surgical treatment. According to a recent Danish study, prolonged OM treated with 
tympanostomy tubes was associated with a higher risk for operatively-treated cholesteatoma 
(0.17%) than was the risk of completely healthy children (0.01%)(Djurhuus et al. 2015). At the 
population level, however, the risk of cholesteatoma was lower in the children who had been 
treated with tympanostomy tubes; each year prior to the fi rst tympanostomy tube insertion 
increased the risk of cholesteatoma by 54% (Djurhuus et al. 2015). 
Th e treatment of CSOM consists mainly of aural toilet and topical antimicrobial treatment. If 
these do not result in the resolution of infection, oral or parenteral antimicrobial treatment may 
be needed. Reconstruction of a perforated TM may be attempted aft er the acute infection has 
been treated. In uncomplicated CSOM, mastoidectomy has not been proven more eff ective than 
conservative treatment, however, in cholesteatomatous CSOM, surgery is indicated (Mittal et al. 
2015).
2.4 Complica? ons of o? ? s media 
Th e rate of suppurative complications of AOM and OME has been reported to be 0.12-0.24% 
(Rosenfeld et al. 2003). Complications of OM may develop following an untreated or incompletely 
treated infection, following infection caused by resistant bacteria, or for unknown reasons. 
Congenital malformations, and anatomical or immunological conditions may predispose a 
patient to complications. Th e thinner bony structures of children may more easily be resorbed by 
infection (Stenfeldt et al. 2014). Although complications of AOM may develop despite adequate 
antimicrobial treatment, most patients with AOM have a very good prognosis. Th e common 
use of antimicrobial treatment has changed the clinical picture of AOM complications and may 
mask symptoms and lead to a prolonged, milder form of disease (latent mastoiditis) (Faye-Lund 
1989). Th orough examination with bacteriological cultures should be performed, especially if a 
patient with AOM does not recover and has high fever, severe general symptoms of infection, 
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secretion from the infected ear, retroauricular signs of infection, hearing problems, dizziness, or 
neurological symptoms. 
OM causes a severe burden in developing countries. According to the WHO, 51,000 deaths 
occur annually in children under the age of fi ve due to intracranial complications of AOM 
(Berman 1995). CSOM has been reported as a major cause of hearing impairment in developing 
countries (Berman 1995). Vaccinations and better treatment of infections are hoped to change 
this situation.
CSOM with cholesteatoma has been associated with intracranial complications (Osma et al. 2000, 
Juliano et al. 2013, Prasad et al. 2013). Th ese complications are caused by the chronic infection 
spreading through bone resorbed by cholesteatoma. In a previous Finnish study, however, more 
complications were found in adult patients with acute, rather than chronic, OM (Leskinen & Jero 
2005).
Th e complications of OM can be divided into intratemporal and extratemporal (extra- or 
intracranial) complications. 
Intratemporal complica? ons
Intratemporal complications of OM, in order of their prevalence, are: mastoiditis, facial nerve 
paresis, petrositis, and labyrinthitis (Bluestone 2000, Kitsko et al. 2007). Morbidity rates for the 
intratemporal complications of OM are reported between 0.4% and 10%, with mortality being 
extremely rare (Osma et al. 2000, Groth et al. 2012). 
Mastoiditis 
Mastoiditis develops when a middle ear infection spreads through the aditus to mastoid antrum 
into the mastoid air cells causing mucosal swelling, local acidosis, ischemia, and resorption 
of bone. Destruction of the bony mastoid septa occurs in coalescent mastoiditis. Coalescent 
mastoiditis can have an acute, aggressive course of disease, or a prolonged, silent course of 
disease known as latent mastoiditis (LM) (Vasquez et al. 2003, Juliano et al. 2013). LM may 
be diffi  cult to diagnose because the TM and middle ear may appear healthy due to a blocked 
aditus to mastoid antrum, behind which the mastoid infection continues. Th e presence of MEE 
with a simultaneous increase in attenuation of the mastoid cells upon CT, along with signs of 
mastoiditis, is called incipient mastoiditis (Vasquez et al. 2003). Acute middle ear infections, 
as well as sub-acute or chronic infl ammation, may cause acute mastoid infections. CSOM with 
cholesteatoma is a common etiology for intratemporal complications (Palva & Pulkkinen 1959, 
Stahelin-Massik et al. 2008, Maranhao et al. 2014). 
Because the diagnosis of mastoiditis is clinical, uniform and accurate diagnostic criteria are 
essential; the most commonly used diagnostic criteria are: postauricular swelling, erythema, 
tenderness, protrusion of the pinna, and a recent episode of (sub)acute OM (van den Aardweg 
et al. 2008, Stalfors et al. 2013). High fever, and a high leukocyte count (WBC) and C-reactive 
protein (CRP) levels may be signs of complicated AM and warrant close follow-up (Bilavsky et 
al. 2009). Because the bacterial etiology of AM is more complicated than that of AOM, bacterial 
cultures of the MEE must always be taken (Luntz et al. 2001, Benito et al. 2007).  
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Debate regarding the necessity of imaging in AM exists; currently imaging is used in cases 
with suspected complications, in unclear cases, or in cases that do not respond to conservative 
treatment (Psarommatis et al. 2012a, Marom et al. 2016). Because it is not always possible to 
clinically rule out intracranial complications, some authors suggest CT imaging of all children 
with AM (Luntz et al. 2012). CT has traditionally been the initial imaging technique for AM; 
good visibility of the mastoid’s bony structures is achieved and intravenous contrast medium 
is used for the better evaluation of soft  tissues (Saat et al. 2015a) (Figure 6).  Th e overall use 
of MRI in clinical practice is rising, it is promising in otological conditions. MRI is good at 
diff erentiating soft  tissues, and at detecting possible intracranial complications (Saat et al. 2015a). 
In patients with AM, MRI is suggested when intracranial complications are suspected (Dobben 
et al. 2000, Vasquez et al. 2003, Minks et al. 2013). Incidental mastoid fi ndings in MRIs of healthy 
individuals are possible, and AOM patients (with no mastoid infection) can have intramastoid 
fl uid accumulation (Blomgren et al. 2003, Polat et al. 2011, Juliano et al. 2013). It is, however, 
possible to distinguish between true mastoid infection and incidental MRI fi ndings (Saat et al. 
2015b). 
 Figure 6. Left : A child with acute mastoiditis of the left  side, protrusion of the pinna, retroauricular 
swelling, and redness. Right: CT image, in which a subperiosteal abscess is seen (red arrow) (From 
Laulajainen-Hongisto et al. 2012, with permission of Duodecim)
Mastoidectomy used to be a common treatment for mastoiditis but, currently, more conservative 
treatment is preferrable (Palva et al. 1959, Chesney et al. 2014). Antimicrobial treatment is oft en 
combined with myringotomy or tympanostomy tube insertion, though, in some institutions, 
retroauricular puncture may be attempted in patients with a subperiosteal abscess (Luntz et al. 
2001, Bakhos et al. 2011, Psarommatis et al. 2012a, Psarommatis et al. 2012b). Mastoidectomy, 
as the most reliable and effi  cient procedure, is suggested in patients who do not respond to 
more conservative treatment, or those who have intracranial complications (Quesnel et al. 2010, 
Psarommatis et al. 2012a, Psarommatis et al. 2012b) (Figure 7). 
In our institution, patients with AM are treated with tympanostomy tube insertion and 
antimicrobial treatment consisting of either intravenous cefuroxime or penicillin (penicillin 
in infections caused by StrA), or of other antibiotics according to the results of bacteriological 
cultures. Additionally topical ear drops (usually ciprofl oxacin-hydrocortisone) are given, and 
steroids are used to reduce infl ammation and tissue swelling. Imaging is performed only in cases 
with suspected complications, or those resistant to treatment in which case, mastoidectomy is 
also considered (Kajosaari et al. 2014).
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Facial nerve paresis
Complicated OM can result in facial nerve paresis, which is usually reversible (Kvestad et al. 
2002). Its incidence is currently much lower (0.005%) than in the preantibiotic era (0.5%) 
(Ellefsen et al. 1996). Th e tympanic segment of the facial nerve is most commonly aff ected, 
especially in patients with dehiscence of the bone covering the facial nerve. Paracentesis or 
tympanostomy tube insertion should be performed, and bacterial cultures of the MEE should be 
taken, in patients with facial nerve paresis occurring as a complication of OM (Redaelli de Zinis 
et al. 2003, Kitsko et al. 2007). Most patients can be treated with parenteral antibiotics (which 
cover Hi, Streptococci, and Staphylococci). Mastoidectomy, with or without decompression of 
the facial nerve, may be considered in complicated cases, or in cases not responding to other 
treatment. 
Petrositis
If infection spreads to the apex of the petrous part of the temporal bone (Figure 1) then 
meningeal infl ammation is oft en present, and due to their close proximity, cranial nerves V 
(trigeminal nerve) and VI (abducens nerve) may be aff ected (Juliano et al. 2013). In Gradenigo’s 
syndrome petrous apicitis is accompanied by orbital pain (trigeminal nerve), diplopia (abducens 
nerve), and otorrhea (Heshin-Bekenstein et al. 2014). Treatment consists of antimicrobials, 
tympanostomy tube insertion, and surgical treatment. 
Labyrinthitis 
In labyrinthitis, the inner ear is infl amed due to bacterial infections (suppurative), viral infections, 
or autoimmune infl ammation (serous). Suppurative labyrinthitis may result in permanent 
hearing loss or vertigo. Th e infection usually spreads to the labyrinth through an intact round 
window, or less commonly through the oval window, a congenital perilymphatic fi stula, or 
acquired bone defects. Labyrinthitis may also follow meningitis, in which case infection spreads 
from the subarachnoid space (Kitsko et al. 2007). 
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Patients with labyrinthitis suff er from vertigo, nystagmus, and hearing loss. Diagnosis is based 
on clinical and audiometric fi ndings, though imaging is also useful. MRI is more eff ective than 
CT in detecting signs of labyrinthine infl ammation (Kitsko et al. 2007, Juliano et al. 2013). 
In patients with labyrinthitis, paracentesis should be performed, tympanostomy tube should 
be placed, and microbiological samples should be taken. Treatment consists of antimicrobials 
(those covering the most common pathogens of AOM: Pnc, Hi, and Mc), topical ear drops, and 
steroids; mastoidectomy may be considered in complicated cases or those unresponsive to other 
treatment (Kitsko et al. 2007). 
Labyrinthitis has three stages: acute, fi brous, and ossifi cation (Juliano et al. 2013). Th e 
infl ammation can result in pathologic ossifi cation of the labyrinth, which may be especially 
severe aft er meningitis, and may complicate eventual later insertion of a cochlear implant 
(Kitsko et al. 2007, Juliano et al. 2013). Steroids are used to prevent ossifi cation in patients with 
labyrinthitis (Hartnick et al. 2001).
Extratemporal complica? ons
Extratemporal complications due to OM can be subdivided into intracranial and extracranial 
categories. 
 Figure 8. Extratemporal complications of otitis media. (image by Helena Schmidt, from Laulajainen-
Hongisto et al. 2012, with permission of Duodecim)
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Extracranial complica? ons
Subperiosteal abscess
In AM, bone destruction may extend to the outer bone cortex through which infection may 
spread and result in a subperiosteal abscess (Figure 6, Figure 8). If a middle ear infection spreads 
temporally, it may form a subperiosteal temporal abscess (Luc’s abscess), which does not always 
involve the mastoid (Weiss et al. 2010, Scraft on et al. 2014).
Bezold’s abscess 
If a bone defect exists in the mastoid tip, mastoid infection can spread to the soft  tissues of the 
neck and form an abscess (Betzold’s abscess, Figure 8) (Jose et al. 2003, Vasquez et al. 2003). 
Intracranial complica? ons 
Intracranial complications of OM are possible due to the close proximity of the brain to the ear. 
Infection can spread to the intracranial space by direct spreading of infection, bone erosion, 
retrograde thrombophlebitis, or hematogenous spreading. CSOM with cholesteatoma has been 
associated with intracranial complications of OM (Penido et al. 2005, Szyft er et al. 2012, Sun et al. 
2014). Th e pathogen that causes the initial, underlying infection would also be the one involved 
in any resulting intracranial complication. Children with AM caused by anaerobic bacteria may 
have a higher risk of developing intracranial complications (Zevallos et al. 2009). 
Intracranial complications of OM are, however, rare. Th ey include, in order of prevalence: 
meningitis, dural venous sinus thrombosis, epidural abscess, subdural empyema, and IA 
(Bluestone 2000).  Carotid artery involvement is extremely rare (Vasquez et al. 2003).  
Th e prognosis of patients with intracranial complications of OM, including IAs, has improved 
over time. However, mortality rates ranging from 9-31% have been reported (Osma et al. 2000, 
Sennaroglu et al. 2000, Penido et al. 2005, Dubey et al. 2010, Szyft er et al. 2012). 
Meningitis
Meningitis is a common intracranial complication of OM. Th e annual incidence of otogenic 
meningitis in adults in the United Kingdom is 0.42/100,000, with most cases being due to CSOM 
(Ibrahim et al. 2010). Meningitis can lead to deafness, even when not caused by OM; thus, early 
diagnosis is essential (Barry et al. 1999). If an otogenic infection is suspected in a patient with 
meningitis, myringotomy with bacterial cultures of the MEE should be performed. CT imaging 
of the ear should be performed if a suspicion of predisposing defects exists, in these cases 
mastoidectomy should also be considered. Antimicrobial treatment is the fi rst-line treatment 
for all meningitis patients. Surgery of the ear should only be performed in patients who do not 
respond to antimicrobial treatment within 48 hours (Slovic et al. 2007). 
Intracranial abscesses
Intracranial abscesses (brain abscesses, subdural abscesses, and epidural abscesses) are rare, with 
an annual incidence of 0.4-0.9/100,000 (Brouwer et al. 2014b). IAs may cause life threatening 
sequelae, fortunately, however, the prognosis of IA patients has improved over time; case fatality 
rates have decreased from 40% to 10%, and the rate of patients with full recovery has increased 
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from 30% to 70% between the 1970s and 2010s (Brouwer et al. 2014a). Predisposing factors can 
be identifi ed in most patients: immunosuppressive conditions, acquired or congenital disruptions 
of anatomical borders of the surrounding structures, or a systemic source of infection (Brouwer 
et al. 2014b). Although IAs are a rare complication of OM, and have become less common 
with time, Brouwer et al. found in their recent meta-analysis that 32% of IAs were otogenic 
(Tarkkanen & Kohonen 1970, Brouwer et al. 2014a). Otogenic IAs (oIA) usually develop as a 
complication of (prolonged, chronic) middle ear infection via contiguous spreading (Figure 8). 
Th e lifetime expectancy of a 30 year-old patient with CSOM developing an oIA is 1/200 (Nunez 
et al. 1990). Th e bacteriological etiology of all IAs is aff ected by their underlying cause; the most 
common pathogens of oIAs belong to Streptococcus spp, Bacteroides spp, Prevotella spp, and 
Enterobacteriaceae (Brouwer et al. 2014b).  
Th e most common symptom caused by IAs is headache; fever and an altered level of consciousness 
are oft en absent, and though eventual other neurological signs become more common as the 
abscess grows (Brouwer et al. 2014a; Brouwer et al. 2014b). Th e diagnosis is not always easy to 
make since the diff erential diagnosis of IAs include many neurological and infectious conditions 
(Brouwer et al. 2014b). Prompt treatment is necessary to ensure a better prognosis (Xiao et 
al. 2005, Dubey et al. 2010).  Otogenic IAs should be suspected in patients with prolonged ear 
infection, headache, and neurological symptoms (Lildal et al. 2014). 
CT imaging has resulted in improved diagnostics and has decreased the mortality of IA patients 
(Mathisen et al. 1997, Ratnaike et al. 2011, Brouwer et al. 2014b). Since the clinical diagnosis of 
oIAs is diffi  cult, neuroimaging is important, preferably with MRI (Lildal et al. 2014), and imaging 
of the ear should also be performed. MRI is excellent in diff erentiating between soft  tissues and 
is a valuable tool in diff erential diagnostics (Doebben et al. 2000, Lai et al. 2002, Prashanth et al. 
2011) (Figure 9). 
Antimicrobial treatment should be started as early as possible, usually aft er the IA puncture 
(Brouwer et al. 2014b). Th e initial choice of antimicrobials should be based on the most likely 
pathogen, oft en based on the predisposing condition, and should later be modifi ed according to 
the results of bacterial cultures (Hafi dh et al. 2006, Brouwer et al. 2014b). Recommended, initial 
broad-spectrum antimicrobials are cefotaxime or ceft riaxone with metronidazole; alternatively, 
meropenem with vancomycin, if Sa is suspected (Brouwer et al. 2014b).
Glucocorticoids may also be needed to reduce cerebral edema (Brouwer et al. 2014b). In selected, 
mild IA cases (also oIAs), only antimicrobial treatment may be attempted (Isaacson et al. 2010). 
Neurosurgical treatment is needed to obtain bacteriological cultures, and to reduce the size of 
the abscess; these can be achieved by puncture, but in some cases extirpation may be needed 
(Brouwer et al. 2014b). Th e underlying cause of the infection must also be treated (Osborn et 
al. 2011). Th e timing of the operations due to oIAs varies and depends on the clinical condition 
of the patient (Seven et al. 2005, Wanna et al. 2010). Many authors report treating the ear and 
IA simultaneously (Kurien et al. 1998, Sennaroglu et al. 2000, Hafi dh et al. 2006, Syal et al. 
2006, Morwani et al. 2009), with some suggesting treatment of the ear within the fi rst 24 hours 
(Kuczkowski et al. 2006). In our institution, the IA is usually treated fi rst, followed by treatment 
of the infected ear once the patient is stabilized. 
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Brain abscess
Brain abscesses are intracranial abscesses located 
within the brain tissue. Otogenic IAs are typically 
located in the temporal lobe, or are cerebellar 
(Couloigner et al. 1998). 
Epidural abscess
Epidural abscess formation usually follows bone destruction associated with coalescent 
mastoiditis. Th ese abscesses are situated in the epidural space, and patients may be silent of 
symptoms for them (Vasquez et al. 2003).   
Subdural abscess
Subdural abscesses are located in the restricted subdural space. Patients with subdural empyema 
oft en have severe symptoms (Vasquez et al. 2003).   
Sinus thrombosis
Dural venous sinus thrombosis usually results from an extradural abscess, but may also develop 
following an epidural abscess, or via osteothrombophlebitis. Infection spreads to the sigmoid 
sinuses or the transverse sinus, where an infectious thrombus may develop (Vasquez et al. 2003, 
Stam 2005, Ropposch et al. 2011) (Figure 8). Th e infected thrombus may continue into the jugular 
vein, to other dural sinuses, or to the subcutaneous tissue via emissary veins. Patients may have 
no symptoms, only mild symptoms, or severe infection with neurological symptoms (Stam et 
al. 2005). CT or MRI are used in the diagnostics of this complication (Vasquez et al. 2003, Stam 
2005, Sharma et al. 2015). In otogenic sinus thrombosis, the underlying ear infection should be 
examined and treated. Treatment of the sinus thrombosis itself, however, remains controversial; 
ligation of the internal jugular vein and anticoagulants have been used.  
Otitic hydrocephalus
If the contralateral sigmoid sinus is hypoplastic in a patient with otogenic sinus thrombosis, 
absorption of the cerebrospinal fl uid may become disturbed resulting in increased intracranial 
pressure and otitic hydrocephalus. Th e pathogenesis of otitic hydrocephalus is, however, not 
completely understood. Symptoms include headache, drowsiness, nausea, blurred vision, diplopia 
and photophobia; in patients with such symptoms, imaging with MRI should be performed. Both 
the underlying ear infection and the elevated intracranial pressure must be treated (with steroids, 
hyperosmolar dehydrating agents, and/or neurosurgery) (Stam 2005, Sadoghi et al. 2007).   
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 Figure 9.  Coronal T2 MR-image of a left -sided occipital 
brain abscess, 2cm in diameter, surrounded by marked 
edema. (Image from Antti Markkola)
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3 AIMS OF THE STUDY
Th e aim of this study was to evaluate the complications resulting from otitis media at our 
institution.
 
Th e specifi c study aims were:
1. To evaluate the clinical picture of acute mastoiditis caused by diff erent pathogens in children. 
2. To study diff erences in the etiology and clinical picture between acute mastoiditis and 
hospitalized acute otitis media in children. 
3. To study the predisposing factors for the development of otogenic intracranial abscesses.
  
4. To analyze clinical characteristics of adults hospitalized due to acute otitis media or acute 
mastoid infections.
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4 PATIENTS AND METHODS
4.1  Diagnos? c and inclusion criteria 
Acute o? ? s media (AOM)
Acute fever (≤14 days), earache, or respiratory symptoms. MEE, bulging, redness, or abnormal 
mobility of the TM upon otomicroscopy. Recent onset of otorrhea not due to otitis externa. 
Acute mastoidi? s (AM) 
Diagnosis of AOM, and at least two of the following symptoms: protrusion of the pinna; 
retroauricular redness, swelling, pain, or fl uctuation; and/or abscess in the EAC; and/or purulent 
secretion or acute infection in the mastoid process upon mastoidectomy. 
Latent mastoidi? s (LM)
Symptoms of acute mastoid infection in adult patients (≥17 years old) who did not fulfi l all the 
study criteria for AM, or who had a prolonged (> 14 days) duration of symptoms.
Acute mastoidi? s of a chronic ear (AMc)
Adult patients (≥17 years old) with a history of CSOM in the ear with AM.
Intracranial abscesses 
Th e diagnosis was based on clinical fi ndings, laboratory test results, microbiological cultures and 
imaging studies, intra-operative fi ndings, or fi ndings upon a post-mortem autopsy. 
4.2 Pa? ents 
Patient data for studies I, II and IV originated in a retrospective search of the hospital’s electronic 
database for data of all patients hospitalized at the Helsinki University Hospital, Department 
of Otorhinolaryngology between 2003 and 2012. Th e patients with AOM were hospitalized due 
to complications, severe symptoms not responding to antimicrobial treatment, or diffi  culties in 
outpatient treatment.
Patient data for study III originated in a retrospective search for all patients treated at the Helsinki 
University Hospital, Department of Neurosurgery due to IA between 1970 and 2012 (Table 1). 
Table 1.  Patients included in studies composing this dissertation
Study Diagnosis Age, range (years) Number of pa? ents 
I AM 0-16 56
II AOM 0-16  44
III IA 0-83  166
IV AOM, AM, LM, or AMc 17-91  160
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All diagnoses were re-evaluated by the study group according to the diagnostic and inclusion 
criteria. For studies I and II, only one diagnosis was analyzed per patient; if the patient had both 
AOM and AM (bilateral infection), they were analyzed as AM. For studies I and II, recurrence 
aft er three months was considered a new infection. For study III, all immediate postoperative 
infection cases were excluded, while favorable recovery was defi ned as recovery from this 
infection without severe neurological defi cits or health problems and the ability to return to 
independent life. For study IV, only the fi rst infection of each patient, and only one diagnosis 
per patient, was analyzed. If a patient (in study IV) had a bilateral infection with both AOM and 
mastoiditis (AM, LM, or AMc), they were classifi ed as mastoiditis.  
Th e patients were classifi ed as children if they were under the age of 17. For studies I and II, 
children under the age of two were classifi ed as younger children and those older than two as 
older children. 
Th e mean age of the patients with IA was 42; 71% were male and 85% were adults. Of the 25 
children with IAs, 60% were male (mean age of eight). Th e mean age of the patients with oIAs 
was 44; 89% were male and two were children. Th e mean age of the adults hospitalized for AOM, 
AM, LM, or AMc was 47 and 42% were male. Th e mean age of the children hospitalized for 
AOM was 6 and 45% were male. Th e mean age of the children hospitalized for AM was 5 and 
52% were male. 
4.3 Methods
Children hospitalized due to AM (I) and AOM (II)
Th e medical records of all 56 AM and 44 AOM children were retrospectively evaluated. Th e 
data analysis included age, gender, medical history, symptoms and signs of infection, pre- 
and in-hospital medication, surgical treatment, outcome, and results of laboratory tests, 
bacteriological cultures, and radiological examinations. Th e samples for bacteriological cultures 
were taken from MEE through a tympanostomy tube, aspirated from the middle ear through a 
paracentesis, or taken intraoperatively from the mastoid cavity. Th e samples were analyzed at the 
Helsinki University Hospital’s laboratory of microbiology. Th e data from study I was compared 
to that of study II. 
Intracranial abscesses (III)
Th e study material consists of 166 patients. Patient data was analyzed according to age, 
demographics, medical history, predisposing condition, symptoms, abscess location, treatment, 
outcome, and results of bacteriological cultures, laboratory tests and radiological examinations. 
Th e bacteriological samples were taken intraoperatively (via puncture or during craniotomy) 
from the abscess cavity, and were analyzed at the Helsinki University Hospital’s laboratory of 
microbiology. 
Adults hospitalized due to AOM, AM, LM, or AMc (IV)
Th e study material consists of 160 patients. Th e data analysis included age, gender, medical 
history, symptoms and signs of infection, pre- and in-hospital medication, surgical treatment, 
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outcome, and results of laboratory tests, bacteriological cultures, and radiological examinations. 
Samples for bacteriological cultures were taken from MEE through a tympanostomy tube, 
aspirated from the middle ear through a paracentesis, or taken intraoperatively from the 
mastoid cavity. Th e samples were analyzed at the Helsinki University Hospital’s laboratory of 
microbiology. 
4.4 Sta? s? cs
IBM SPSS statistics for Windows, Version 19.0 (IBM Corp., Armonk, NY, USA) was used for 
studies I-III and IBM SPSS statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA. 
Released 2013) for study IV.
Fisher’s exact tests and Chi-square tests, as appropriate, were used to determine the signifi cance 
between categorical variables. Th e Mann-Whitney U test was used to analyze the equality 
of medians between continuous variables. A two-sided p-value of below 0.05 was considered 
statistically signifi cant. 
4.5 Ethical considera? ons
Th e studies were approved by the Research Ethics Committee of Helsinki University Hospital.
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5 RESULTS
Children hospitalized due to AM (I) 
Th e annual incidence of AM in children was 1.88/100,000. Th e childrens’ clinical characteristics, 
symptoms, fi ndings, complications, surgeries, and outcomes are presented in Table 2. Th e most 
common symptoms were otalgia, mastoid tenderness, retroauricular redness, and fever.  
Antimicrobial treatment had been prescribed prior to hospital admission in 70% of patients 
(typically amoxicillin, amoxicillin-clavulanate, and cephalosporines), 55% had been diagnosed 
with a previous AOM. 
Th e bacterial fi ndings are presented in Figure 10. Th e bacterial cultures were negative in 29% 
of cases. Of all Pnc (n=21) samples, 48% (n=10) showed reduced susceptibility to common 
antimicrobials (Table 3); these were clearly overrepresented, relative to the background 
population (19%, p<0.001). Th e children with Pnc had less otorrhea (5, 24% vs 19, 54% in others, 
p=0.03) and more protrusion of the pinna (18, 86% vs 19, 34% in others, p=0.02) than others. 
Th e children with StrA had less otalgia than others (3, 50% vs 46, 82%, p=0.004). Th e children 
with Ps oft en had prior tympanostomy tubes (83%). Children with Ps had the lowest CRP values 
(21) and while retroauricular swelling was not as common in them as others (1, 17% vs. 30, 54%, 
p=0.04) they all had otorrhea (6, 100% vs. 24, 43% in all, p=0.003). Th e patients with negative 
bacterial cultures had less otorrhea (3, 19% vs 21, 38%, p=0.02) and protrusion of the pinna (7, 
44% vs 30, 54%, p=0.03), but more dizziness (3, 19% vs 1, 2%, p=0.03) than others.
All patients received intravenous antimicrobial treatment; the most common being cefuroxime 
(91%), ceft riaxone (16%), and metronidazole combined with another antimicrobe (14%). Steroids 
were administered to 73%, and topical ear drops to 95%. Oral antimicrobial treatment was 
continued aft er hospital discharge in 98%; most commonly cefalosporins (49%) or amoxicillin-
clavulanate (33%).  
Mastoidectomy was performed on 34% of patients. Th e children who had been treated with 
azithromycin prior to hospitalization were more likely to undergo mastoidectomy than others 
(4, 80% vs 11, 28%, p=0.02). Mastoidectomy also tended to be more common in children with 
resistant Pnc (6, 60% vs 13, 23%, not signifi cant). No diff erences emerged in patient outcomes 
regarding type of pathogen or mastoidectomy status. 
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Table 2.  Clinical fi ndings, symptoms, surgeries, and outcome of children hospitalized due to AOM or AM.
AM (n=56) AOM (n=44) p- value
Females 27 (48%) 24 (55%)
Mean age 5.0 6.0
Age < 2 15 (27%) 14 (32%)
Median CRP (mg/l) 66 29 0.008
Bilateral infec? on 9 (16%) 17 (39%) 0.013
Otalgia  49 (88%) 38 (86%)
Fever 40 (71%) 29 (66%)
Otorrhea 24 (34%) 22 (50%)
Dizziness  4 (7%) 11 (25%) 0.022
Nausea 4 (7%) 5 (11%)
Head ache 5 (9%) 2 (5%)
Hearing problem  5 (9%) 4 (9%)
Facial paresis 3 (5%) 12 (27%) 0.004
Retroauricular redness 44 (79%) 10 (23%) <0.001
Retroauricular pain 45 (80%) 7 (16%) <0.001
Retroauricular swelling 31 (55%) 6 (14%) <0.001
Retroauricular ? uctua? on 10 (18%) 0% 0.002
Protrusion of the pinna 37 (66%) 3 (7%) <0.001
Subperiosteal abscess 10 (18%) 0%
Meningi? s 1 (2%) 0%
Gradenigo’s syndrome 2 (4%) 0%
Sinus thrombosis 4 (7%) 0%
Imaging performed 28 (50%) 5 (11%)
Tympanostomy performed 47 (84%) 26 (59%) <0.001
Paracentesis performed 13 (23%) 10 (23%)
Mastoidectomy 34% 0%
Median hospitaliza? on, days 4.0 3.0 0.001
Residual TM perfora? on 1 (2%) 1 (2%)
Residual hearing problem 3 (5%) 2 (5%)
Re-opera? on performed 7 (13%) 8 (18%)
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Figure 10.  Pathogens of all children with acute mastoiditis (AM) (n=56) and  pathogens of younger 
children (age < 2) with AM (n=15) 
 Table 3. Resistant S. pneumoniae cases (n=10) in children with acute mastoiditis. 
(MIC = minimal inhibitory concentration, S=susceptible, I=intermediate, R=resistant) 
Received 
an? microbial 
treatment
Penicillin 
(MIC mg/l)
1st and 2nd 
genera? on 
cefalosporin
3rd genera? on 
cefalosporin
Sulfa-
trimetho-
prim
Macrolide Clinda-
mycin
Mastoid-
ectomy
1 Yes I (0.75) R S I I S Yes
2 No I (1) S S R S S No
3 Yes I (0.094) S S S R R No
4 Yes I (0.125) S S I R R Yes
5 Yes I (0.094) Missing Missing S S S No
6 Yes R (2) R S R R R No
7 Yes R (4) R I R R I Yes
8 Yes R (4) R I R R R Yes
9 Yes I (0.75) R S R R R Yes
10 Yes I (0.125) S S R S S Yes
Children hospitalized due to AOM (II) 
Th e annual number of children hospitalized due to AOM was 1-9 (over the study’s 10 year period: 
12 cases in spring, 7 in summer, 17 in autumn, and 8 in winter). Patient clinical characteristics, 
symptoms, fi ndings, complications, procedures, and outcomes are presented in Table 2. Th e most 
common symptoms were otalgia, fever, and otorrhea. 
Antimicrobial treatment had been prescribed to 57% (n=25) prior to hospital admission 
(typically amoxicillin, penicillin, or cephalosporines).
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Th e bacterial fi ndings are presented in Figure 11. Samples for bacteriological culture were 
taken from 38 children (86%). Mixed fl ora was found in the cultures of fi ve children (11%). Th e 
cultures were negative in 11 children (25%), typically those who had received antibiotics prior to 
hospitalization (38% vs 6% in those who had not received antibiotics, p=0.016). Antimicrobial 
resistance was only seen in one of the Pnc cases (13%) (penicillin MIC (minimal inhibitory 
concentration) 0.19 mg/l, all were susceptible to cefalosporins). Otorrhea via prior tympanostomy 
tubes was more common in the children with Ps than others (71% vs 5%, p=0.000). Otorrhea 
occurred in all children with StrA, which was much more than in children with other pathogens 
(p=0.021). 
All patients received antimicrobial treatment, typically intravenously (75%), with cefuroxime 
(57%) and ceft riaxone (18%) being most common. Steroids were administered to 55% and 
topical ear drops to 86%. Per oral antimicrobial treatment was continued aft er hospital discharge 
in 95%; amoxicillin-clavulanate (33%), amoxicillin (26%) and cefalosporins (24%) were most 
common.  
 Figure 11. Pathogens of all children hospitalized due to acute otitis media (AOM) (n=44)  and 
pathogens of younger children (age < 2) hospitalized due to AOM (n=14). Note: Hi was not found in 
any sample. 
Comparison of children hospitalized due to AM and AOM (I,II) 
Th e annual number of hospitalized AOM and AM patients are shown in Figure 12. Prior health 
problems (such as asthma, diabetes, developmental disorders, ear problems) were more common 
in children with AOM than AM (48% vs 27%, p=0.037). 
Retroauricular symptoms were more common in children with AM than AOM (Table 2), and 
these signs of infection were rare in patients with facial nerve paresis compared to those without 
it: retroauricular swelling (0% vs 44%, p=0.001), retroauricular redness (0% vs 64%, p=0.000), 
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retroauricular pain (7% vs 60%, p=0.0001), and protrusion of the pinna (0% vs 47%, p=0.000). 
All children with facial nerve paresis were treated with tympanostomies, while only 68% of those 
without paresis had the surgery (p=0.009). 
Pnc was more common in children with AM than AOM (38% vs 18%, p=0.046), especially the 
resistant strains (48% vs 13% of all Pnc, p=0.021). Younger children were more likely than older 
children to have infections due to Pnc (59% vs 17%, p=0.000) and its resistant strains (24% vs 
6%, p=0.013). No signifi cant diff erences were found in the prevalence of Ps or StrA between 
children with AM and AOM. Th e younger children, however, did not have Ps (compared to 18% 
in the older children, p=0.018) or StrA (compared to 17% in the older children, p=0.017). Sa was 
less common in children with AM than AOM (2% vs 14%, p=0.042). 
 Figure 12. Annual number of children hospitalized for acute otitis media (AOM), or acute mastoiditis 
(AM). 
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Intracranial abscesses (III) 
Th e total number of IAs was 166, with a mean annual number of four cases (range 1-8) (Figure 
13). Th e annual incidence of IAs was 0.33/100,000 (2000-2012), and the proportion of children 
decreased with time (24% in 1970-1989 vs 8% in 1990-2012, p=0.004). Th e etiology in 18 (11%) 
patients was otological (Table 4); these oIA cases were most common in 1970-1979 (10 cases, 
25%) and their incidence decreased over time (2000-2012: 3 otogenic cases, 5%) (Figure 13). Th e 
annual incidence of oIAs (2000-2012) was 0.017/100,000. Over time, cardiac anomalies among 
IA cases became less common (15, 20% in 1970-1989 vs. 6, 7% in 1990-2012, p=0.001), whereas 
odontogenic infections became more common. 
Th e median symptom duration of IA patients prior to hospitalization was 10.0 days (0-90 
days), though it was shorter in patients with odontogenic infection (4.5 days, p<0.001). Prior 
to hospitalization, 19% of all IA patients had received antimicrobial treatment; oft en these were 
patients with ENT infections (49% vs 3% of all other patients, p<0.001). Th e most common 
presenting symptoms were headache (48%), fever (28%), and some focal neurological symptom 
(21%). 
Nearly all IA patients (99%) underwent some imaging, with a singular abscess being found in 
most cases (87%). Multiple abscesses were more common in children than adults (28% vs 11%, 
p=0.048). Patients with ENT infections had more temporal abscesses than others (43% vs 12%, 
p<0.001). Patients with sinusitis had more extra-axial abscesses (i.e. empyemas) than others 
(40% vs 3%, p<0.001). Temporal abscesses were more common in patients with oIAs than in 
those with other etiologies (78% vs 12%, p<0.001). 
Pathogen results from bacteriological culture are shown in Table 5. Fusobacteria were more 
common in patients with odontogenic infection than others (9, 38% vs 14, 10%, p=0.001). Gram-
negative enteric bacteria were more common in patients with oIA than others (4, 22% vs 4, 3%, 
p=0.005).
Antimicrobial treatment was common during hospitalization (96%); the most common (2000-
2012) being: cephalosporins (95%), nitroimidazoles (72%), meropenem (31%), and vancomycin 
(28%). Preoperative corticosteroids were administered to 74%. Nearly all IAs were treated with 
surgery (99%).
A favorable recovery was seen in 66%, with 19% being able to return to their prior occupation 
(12 % in 1970-1989 and 24% in 1990-2012). Th ose that could return to their prior occupation 
were typically patients that had no predisposing conditions for their IA (52% vs 28% of others, 
p=0.018) and were younger (mean age 29 vs. mean age 45). 
Twelve patients (11 adults and one child) died due to the IA. Death due to abscess became less 
common over time (12% in 1970-1989 vs 3% in 1990-2012, p=0.037). 
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Figure 13. Th e annual number of otogenic intracranial abscesses (oIA) and of intracranial abscesses 
of other etiologies (other IA). 
Table 4.  Intracranial abscesses with ENT or dental predisposing conditions. (* p<0.01)
All (166) Adults (141) Children (25) 1970-1989 (74) 1990-2012 (92)
ENT infec? on 37 (22%) 27 (19%) 10 (40%) 21 (28%) 16 (17%)
O? ? s 18 (11%) 16 (11%) 2 (8%) 10 (14%) 8 (9%)
Sinusi? s 15 (9%) 8 (6%) 7 (28%)* 8 (11%) 7 (8%)
Dental infec? on 24 (15%) 23 (16%) 1 (4%) 3 (4%) 21 (23%)* 
Table 5.  Pathogen fi ndings of patients with otogenic intracranial abscesses (oIA) and of intracranial 
abscesses of other etiologies (other IA). (* p<0.01)
oIA other IA
Streptococcus spp 33 % 42 %
Gram-nega? ve enteric bacteria* 22 % 5 %
Bacteroides spp 11 % 4 %
Fusobacterium spp 6 % 14 %
Haemophilus spp 6 % 4 %
Staphylococcus spp 0% 8 %
Ac? nomycetales 0% 8 %
Other/unknown 22 % 15 %
Nega? ve culture 17% 14%
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Adults hospitalized due to AOM, AM, LM, or AMc (IV) 
Th e annual incidence of AM in adults was 0.4/100,000, and that of all mastoid infections (AM, 
LM, or AMc) was 0.8/100,000. Th e annual number of cases is shown in Figure 14; no signifi cant 
seasonal variation was seen. Patient clinical characteristics, symptoms, fi ndings, complications, 
procedures, and outcomes are presented in Table 6. Th e median duration of symptoms was 8 
days and was longest in patients with LM (10 days). 
Prior medical conditions (such as asthma, diabetes mellitus, cardiac disease, ear problems) were 
seen in 99 patients (62%). Cardiac problems were most common in the AMc group (5, 25% vs. 
10, 7% in others, p=0.024). While all patients with AMc had CSOM, most patients (73%) had 
no prior ear problems; only fi ve (3%) had a prior tympanostomy tube. A history of prior ear 
problems was least common in patients with AM (5, 10% vs. 38, 35% in others, p=0.001), these 
patients also had fewer general prior medical conditions (26, 50% vs. 73, 68% in others, p=0.036). 
Prior antimicrobial treatment had been administered to 114 patients (71%) and ear drops to 40 
patients (25%). Patients with AMc had received less prior antimicrobial treatment than others 
(10, 50% vs 104, 74% in others, p=0.034).
Imaging was commonly performed on patients, with CT performed on 104 (65%) and MRI 
on 35 (22%); AOM patients were least likely to have had imaging. Th e most common cultured 
pathogens were StrA (19%), Pnc (14%), and Ps (11%); pathogens are shown according to groups 
in Figure 15. Hi was only found in the samples of three patients. Of all Pnc cultures, four (18%) 
had reduced susceptibility for common antimicrobials. Ps (30%, p<0.01), and Sa (25%, p<0.05) 
were more common in patients with AMc than in others. Th e results of bacterial cultures were 
negative for 65 patients (41%), making up 57% of AOM samples, 35% of AM samples, 25% of LM 
samples, and 30% of AMc samples. Patients with infection caused by Pnc had a longer duration 
of hospitalization (7 days vs 4 days in others, p=0.000), higher median CRP (216 vs 28 in others, 
p=0.000) and median WBC levels (14.4 vs 10.5 in others, p=0.009), and more meningitis (5, 
23% vs 4, 3% in others, p=0.003) compared to those with infections caused by other pathogens. 
Otorrhea (83%), TM perforations (57%), hearing problems (83%), and post-infection hearing 
problems (60%) were common in patients with infection caused by StrA.  Additionally, dizziness 
was relatively common in these patients (57%). Otorrhea (94%) and retroauricular signs of 
infection were common in patients with infection caused by Ps. 
Parenteral antimicrobial treatment was administered to most patients (98%) (cefuroxime 84%, 
ceft riaxone 11%, and/or metronidazole 10%), as well as peroral antimicrobial treatment to (92%) 
(cephalexin 55%, amoxicillin-clavulanate 22%, ciprofl oxacin 18%). Additionally, topical ear 
drops (88%) and steroids (79%) were commonly prescribed. 
Mastoidectomy was performed on 44% of patients. Th e mean duration of hospitalization was 
longer in patients who underwent mastoidectomy (8 days) compared with those who did not (5 
days, p=0.001). 
Outcomes were better in patients who did not need a mastoidectomy. Full recovery was 
comparatively less common in patients with infection caused by Ps (24%). Post-infection hearing 
problems were common in patients with infection caused by Sa (62%) or StrA.
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Figure 14.  Annual number of adults hospitalized for acute otitis media (AOM), acute mastoiditis 
(AM), latent mastoiditis (LM), or AM in chronic ear (AMc). 
Results
 
0
2
4
6
8
10
12
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
AOM AM LM AMc
44
Table 6.  Clinical fi ndings, symptoms, surgeries, and outcomes of adults hospitalized due to AOM, AM, 
LM, or AMc.
 AOM (60) AM (52) LM (28) AMc (20)
Females 67% 60% 43% 45%
Median age 43 47 49 52
Median CRP(mg/l) 11 81 24 12
Otalgia 97% 100% 86% 95%
Fever 32% 44% 39% 35%
Otorrhea 43% 64% 64% 90%
Dizziness 53% 44% 43% 30%
Nausea 23% 21% 14% 5%
Head ache 13% 23% 18% 15%
Hearing problem 67% 69% 68% 25%
Facial nerve paresis 17% 12% 18% 5%
Retroauricular redness 2% 23% 4% 40%
Retroauricular pain 12% 65% 25% 60%
Retroauricular swelling 0% 23% 4% 45%
Retroauricular ? uctua? on 0% 2% 4% 30%
Protrusion of the pinna 0% 12% 0% 20%
Subperiosteal abscess 0% 2% 10% 35%
Meningi? s 0% 8% 11% 10%
Labyrinthi? s 38% 15% 18% 5%
Sinus thrombosis 0% 4% 4% 0%
Tympanostomy 55% 73% 71% 45%
Paracentesis 75% 71% 79% 35%
Mastoidectomy 7% 37% 54% 50%
Median hospitaliza? on, days 4 6 5 4
Residual TM perfora? on 13% 13% 18% 30%
Residual hearing problem 37% 35% 32% 20%
Re-opera? ons 8% 13% 21% 25%
Results
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 Figure 15. Pathogens of adults hospitalized for AOM (n=60), AM (n=52), LM (n=28), or AMc (n=20). 
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6 DISCUSSION
Complica? ons of o? ? s media
According to our results, complications of OM in children and adults are less common in Finland 
than in other European countries. Th e annual incidence of AM among Swedish and Dutch 
children is 2.5-3.8/100,000 (van Zuijlen et al. 2001, Groth et al. 2012). Th e annual incidence of 
mastoiditis in Italian adults is 1.0/100,000 with 31% of those due to chronic OM (Palma et al. 
2014). In our study, AM was more common in children than adults. Th e annual incidence of AM 
in children was 1.9/100,000, whereas the annual incidence of acute mastoid infections (AM, LM, 
or AMc) in adults was 0.8/100,000. Only 13% of our adult patients had AMc, possibly explaining 
our lower incidence compared to the Italian study. One explanation for the lower incidence of 
AM in Finnish children compared to Sweden or the Netherlands, might be the reduced use of 
antimicrobial treatment in those countries.  
Complications due to OM have recently become more common at our institution compared 
with earlier reports (1990-2004) in which annual OM complication incidences of 1.1/100,000 in 
children and 0.3/100,000 in adults were reported (Leskinen & Jero 2004, 2005). Th e diagnostics 
of OM and its complications have not been altered over this time period, and thus do not explain 
this change. Reasons for this rise in incidence may be due to changes in the treatment of OM or 
pathogen virulence.   
Th e annual incidence of IAs, according to a recent meta-analysis, is 0.4-0.9/100,000, with 32% 
being oIAs (Brouwer et al. 2014a). Some of the studies included in this meta-analysis were old, 
possibly skewing the incidence rates to appear higher than are currently seen in practice. In our 
study, the annual incidence for oIA over 2000-2012 was much lower, 0.02/100,000. Our results 
also show that the incidence of oIA has decreased over time, and that the prognosis of patients 
with IAs has improved. In our patients, most oIAs were due to CSOM and cholesteatoma, and 
ear symptoms were common in this group (17 patients, 94%) (unpublished data, Laulajainen-
Hongisto et al.). Th e decrease in the incidence of chronic OM may explain the simultaneous 
decrease in the incidence of oIAs. 
Pathogens of complicated o? ? s media
Th e most common pathogens of outpatient AOM in children are Pnc (23%), Mc (18%), and Hi 
(16%) (Palmu et al. 2004). Studies regarding the pathogens of AOM in adults are scarce, perhaps 
because outpatient AOM is uncommon in adults; the most common pathogens in adults with 
AOM have been reported to be Pnc (21%), Hi (26%), StrA (4%), and Mc (3%) (Celin et al. 1991, 
Bluestone et al. 1992). 
Our study results are in accordance with prior literature fi ndings that the bacteriological etiology 
of complicated OM diff ers from outpatient AOM (Luntz et al. 2001, Leskinen 2005, Benito et 
al. 2007); our results show that this diff erence in bacteriological etiology of outpatient AOM 
from hospitalized AOM and AM occurs in both children and adults. Th erefore, bacteriological 
cultures should always be taken in complicated cases of OM in order to determine the proper 
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course of treatment as early as possible. We found that Pnc, StrA, and Ps were the most common 
pathogens in both adults and children with complicated OM; StrA and Ps were, however, only 
seen in adults and children older than two years.
Recent prior antimicrobial treatment was more common in adults (71%) than children (64%). In 
children, it tended to be more common in AM (70%) than AOM (57%), and in adults it was least 
common in AMc (50%). Our results show that culture negative bacterial fi ndings were associated 
with prior antimicrobial treatment; these fi ndings were less common in children (27%) than 
adults (41%), they were uncommon in adults with AMc (30%). Antimicrobial resistance 
(especially of Pnc to penicillin) is more common in children who have had prior antimicrobial 
treatment (Leibovitz et al. 1998, Del Castillo et al. 1998).
We found Pnc to be common in both outpatient AOM and complicated OM. In this study, Pnc was 
found in 38% of childen hospitalized for AM, 21% of adults hospitalized for LM, 19% of adults 
hospitalized for AM, 18% of children hospitalized for AOM, and in 10% of adults hospitalized 
for AOM, but not in oIAs or adults with AMc. Pnc, including its resistant strains, were common 
in children under two years of age. More Pnc strains with resistance to penicillin and 1st and 
2nd generation cefalosporins were seen in children with AM (48% of Pnc) than in children with 
AOM (13% of Pnc), or in adults (18% of Pnc). Th is might be due to the resistant, more virulent 
Pnc strains being able to more easily cause complicated infections, or due to selection of resistant 
strains due to prior antimicrobial treatment. Drug-resistant strains are not necessarily more 
virulent, but may be treated with ineffi  cient antimicrobials more oft en. Fortunately, a high and 
frequent-enough dosage of antimicrobials can compensate for the intermediate resistance of Pnc 
to penicillin (Del Castillo et al. 1998, Jalava 2014). Adults had less infections caused by these 
resistant Pnc strains, even though they had received more preceding antimicrobial treatment 
(71%) compared with children (64%). In children, pneumococcal infections (especially those 
caused by the resistant strains) caused more severe symptoms and led to more mastoidectomies 
than infections caused by other pathogens. Multi-drug resistant Pnc is, according to the literature, 
common in complicated AOM (Mattos et al. 2014, Antonelli et al. 1999, Zapalac et al. 2002). 
More antimicrobial resistance of Pnc to penicillin, macrolides, and trimethoprim-sulfonamide 
was observed in Finland over the period 2009-2011, compared to 2014 (Jalava 2014). Our study 
fell into this 2009-2011 period, but this does not explain why children with AM, in particular, 
had such high rates of resistant Pnc strains. 
In this study, Hi was a very rare fi nding (0-4%) in complicated OM among both children and 
adults. Mc was most oft en found in children under the age of two who were hospitalized for 
AOM (14%), but it was not seen in adults or children with AM. Our results confi rm the fi ndings 
of earlier reports, that Hi and Mc rarely cause complications of OM (Katz et al. 2003, Leskinen & 
Jero 2003, Segal 2005). 
In our study, StrA was oft en found in adults and older children, but not in younger children. 
It was common in adults hospitalized for AM (27%), LM (25%), and AOM (15%), but not in 
adults with AMc. In adults, StrA caused otorrhea, TM perforations, disturbances in balance, 
and hearing problems. To enable a faster diagnosis of infections caused by StrA, rapid detection 
from MEE can be used. StrA is known to be virulent and locally invasive (Segal 2005, Shulman 
et al. 2005). Th e incidence of invasive StrA infections in children has tripled within the last 15 
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years in Finland (Tapiainen et al. 2016). Some strains of StrA have the ability to release bacterial 
toxins that can, at worst, result in a cytokine storm leading to toxic shock syndrome with tissue 
damage, disseminated intravascular coagulation, and multiorgan dysfunction (Lappin et al. 
2009). Th erefore, it is easy to understand how tissue damage caused by bacterial toxins entering 
the labyrinth or cochlea can result in serious complications. 
Ps has been reported to be a common pathogen in AM, especially in children with prior recurrent 
AOM (Butbul-Aviel et al. 2003). Ps was found in adults with AMc (30%), children hospitalized 
for AOM (16%) or AM (11%), and adults hospitalized for AM (10%) or AOM (8%), but it was 
not among the most common pathogens in adults with LM. In our material, Ps caused otorrhea 
and was found in older children, especially those with prior tympanostomy tubes, as well as 
adults with chronic OM. In children, the clinical picture of AM caused by Ps was mild.
Th e bacteriological etiology of AMc was not like that of AOM, LM, or AM. As expected, the 
bacteriological etiology of AMc - Ps (30%), Sa (25%), and Gram-negative enteric bacteria (20%) 
- resembled the bacteriology of CSOM (Brook 2005, Yeo et al. 2007, Mittal et al. 2015).
In our material, most patients with oIAs had preceding CSOM with cholesteatoma. An association 
of CSOM with cholesteatoma, with intracranial complications of OM has been seen previously 
as well (Penido et al. 2005, Szyft er et al. 2012, Sun et al. 2014). According to the literature, the 
most common pathogens of oIAs belong to Streptococcus spp, Bacteroides spp, Prevotella spp, and 
Enterobacteriaceae (Brouwer et al. 2014b), which are similar to those seen in CSOM patients. In 
our study, Gram-negative enteric bacteria were more common in patients with oIAs (22%) than 
in others. Th e bacteriological etiology of oIA resembles that of chronic OM and AMc.  
Complicated o? ? s media in children and adults 
In our study, the children with AM were generally younger than those with AOM. However, 
there were more children under the age of two in the AOM group (32%) than AM group (27%). 
AM causes a more severe clinical picture in younger children, compared to those who are 
older (Katz et al. 2003). AM has been reported as very uncommon in infants under the age of 
six months (17 cases in Sweden over a 15 year period) (Stenfeldt et al. 2014). In our material, 
AM was clearly less common in children under the age of two than in a Swedish study (55%) 
(Groth et al. 2012). Although the expectant observation approach for AOM in older children 
is more clearly suggested in Sweden than Finland, antimicrobial treatment is recommended for 
AOM in children under the age of two in both countries (Heikkinen et al. 2010, Stenfeldt et 
al. 2010, Groth et al. 2011). Th e adults with AOM or AM were younger than those with more 
prolonged infections (LM, AMc); this may be explained by the complications of OM being along 
a continuum, starting from AOM, progressing to either AM or LM, which, if not treated, can 
lead to CSOM and AMc. Most oIAs developed following CSOM, which is more common in 
adults than children.   
Underlying medical problems were more common in children hospitalized for AOM (48%) than 
AM (27%), while adults with AMc had more prior medical conditions, including ear problems; 
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this was most likely due to their older age compared with adults in other groups. Th e chronic ear 
problems of adults with AMc persisted aft er the acute mastoid infection. 
Intra- and extratemporal complica? ons of o? ? s media 
In the present study, subperiosteal abscesses were more common in children with AM (18%) 
than in adults (6%), probably due to the thinner bone structures in children than adults and 
the immature immune system of children. Subperiosteal abscesses were more common in adults 
with AMc than other types of acute mastoid infections or AOM. Th e patients with AMc probably 
had more underlying bone destruction due to their chronic middle ear infection. 
Facial nerve paresis was more common among children hospitalized due to AOM (27%) than 
AM (5%). Th is can be explained by the spread of infection in the direction of least resistance. If 
the infection spreads toward the mastoid, it causes less pressure on the facial nerve area. In our 
study, 14% of adults had facial nerve paresis and 23% had labyrinthitis. AOM and AM patients 
with facial nerve paresis typically have infected tissue and purulent eff usion surrounding an 
uncovered facial nerve.
In our patients, oIAs were usually due to CSOM with cholesteatoma. According to Zevallos et 
al. (2009), 25% of pediatric patients with coalescent AM may have intracranial complications. 
We found intracranial complications of AM to be much less common. Additionally, the rate of 
intratemporal complications due to OM reported in a Brazilian study (0.8%) seems very high 
compared to our results (Maranhao et al. 2014). 
Diagnos? cs of complicated o? ? s media 
Th e diagnosis of mastoiditis is based on symptoms and clinical fi ndings (protrusion of the pinna, 
retroauricular redness, swelling, pain, or fl uctuation; and/or abscess in the EAC; and/or purulent 
secretion or acute infection in the mastoid process upon mastoidectomy), not imaging or 
laboratory tests. Since AOM, AM, LM, and AMc are part of a continuum of middle ear infection, 
their symptoms overlap. 
In our study, children with AM had more protrusion of the pinna than the children with AOM. 
Also, retroauricular signs of infection were more common in children with AM than AOM. Th e 
criteria we chose to use for the diagnosis of AM, therefore, seem appropriate.  
Fever, otorrhea, and otalgia did not diff er signifi cantly in children with AOM and AM. In 
our material, fever was more common in adults with AM than in other groups. According 
to the literature, high fever and elevated infectious parameters (WBC, CRP) may be signs of 
complicated AM and warrant close follow-up (Bilavsky et al. 2009). We also found that patients 
with AM had higher CRP levels than those with AOM. 
Th e necessity of imaging in AM has been discussed; currently, imaging is mainly performed 
to detect complications in unclear cases, or in cases that do not respond to treatment. In 
concordance with this, imaging was, in our study, less common in children with AOM (11%) 
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than AM (50%), and less common in adults with AOM (CT 28%, MRI 5%) than LM (CT 93%, 
MRI 43%). Imaging is crucial in the diagnostics of IAs, as well as in diagnosing the underlying 
conditions of the ear. CT is effi  cient in evaluating bony structures, but MRI is superior in 
evaluating soft  tissues and intracranial structures; the choice of imaging technique should be 
based on the type of anatomical structures in question. Th e availability of CT is better than 
that of MRI, and its duration is shorter. Anesthesia may be needed when MRI is performed on 
small children. All of these factors aff ect the choice of modality; nevertheless, imaging should 
be considered in patients with acute infection of the middle ear and signs of mastoid infection 
that do not respond to conservative treatment (within 48 hours), when surgical treatment is 
considered, or when complications are suspected. 
Treatment of complicated o? ? s media
Ideally, we would be able to identify those AOM patients who are at risk for development of 
complications as early as possible and treat their infections effi  ciently before complications 
develop. Antimicrobial treatment is not only used to avoid complications of AOM, but also to 
reduce symptoms, shorten the duration of MEE, and to avoid hearing problems in children 
(Tapiainen et al. 2014). According to Swedish publications, watchful waiting does not seem to 
increase the incidence of AM (Stenfeldt et al. 2010, Groth et al. 2011). However, the incidence of 
mastoid complications of AOM in Sweden and the Netherlands, where antimicrobial treatment 
for AOM is less common, is much higher than in Finland (van Zuijlen et al. 2001, Groth et al. 
2012). It is known that antimicrobial treatment reduces the risk of mastoiditis, but the number 
of treated AOM patients needed to avoid one case of AM is very high (~4800) (Petersen et al. 
2007, Th ompson et al. 2009). Since spontaneous resolution of AOM is seen within 2-3 days of 
symptom onset in 80% of patients, those with no known risk for complications can simply be 
followed (Rosenfeld et al. 2003). Based on the literature and our results, antimicrobial treatment, 
at least for AOM in children under the age of two, seems adequate (Klein 2011, Tähtinen et al. 
2011, Hoberman et al. 2011a, Hoberman et al. 2013). 
Th e factors leading to complications are not entirely known. Complications may develop 
following untreated infections, incompletely treated infections (LM), or, in some cases, due 
to unknown causes, despite eff ective treatment. Anatomical or immunological factors, as well 
as age, may aff ect a patient’s predisposition for complications. Additionally, the virulence, or 
antimicrobial resistance, of a pathogen may aff ect its ability to cause complicated infections 
(Antonelli et al. 1999, Zapalac et al. 2002).
In our study, children with AM had received more antimicrobial treatment prior to hospitalization 
(70%) than children with AOM (57%). Many of the pathogens of OM are naturally resistant to 
macrolides. In our study, the children with AM who had been treated with macrolides underwent 
more mastoidectomies (80%) compared to the whole group (34%). Macrolides should not be 
used to treat AOM since almost all Hi strains, and 14-27% of Pnc, are resistant to them.  
All study patients with AOM or mastoid infection received antimicrobial treatment; cefuroxime 
was the most common, followed by ceft riaxone, clindamycin, and metronidazole. Ciprofl oxacin-
hydrocortisone ear drops were commonly administered to the patients (~90%) to treat the 
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infection and keep the tympanostomy tube open. In order to reduce infl ammation and tissue 
edema, oral or parenteral steroids were given to 55-73% of children and 79% of adults.    
We advise that the antimicrobial treatment of complicated OM should always cover Pnc and 
StrA. In the Finnish current care guidelines for treatment of AOM, the suggested amoxicillin 
dose is 40mg/kg/day, whereas guidelines from the United States suggest an amoxicillin dose of 
80-90mg/kg/day (Heikkinen et al. 2010, Lieberthal et al. 2013). Since antimicrobial resistance 
of Pnc was common in our pediatric sample of AM, and most Pnc cases were intermediately 
resistant to penicillin, a higher dose of antimicrobials should be considered for this group.  
Th e patients with AM required longer hospitalization and more surgeries than those with AOM. 
In adults, surgeries were more common in the patients with prolonged mastoid infections (LM, 
AMc) than in those with AOM or AM.  Paracentesis was performed more commonly in adults 
(69%) than children (23%), and tympanostomies less commonly in adults (63%) than children 
(73%). Tympanostomy was more common in children with AM (84%) than with AOM (59%). 
Although the treatment of mastoiditis has become more conservative, mastoidectomy is still 
required in AM resistant to conservative treatment (Chesney et al. 2014). Mastoidectomy was 
performed on 34% of children with AM, and on 44% of all adult patients with AM, LM, or AMc. 
In adults, mastoidectomy was most common in LM (54%). Th e adult patients that underwent 
mastoidectomy had worse outcomes than those who did not, however, none had perioperative 
complications. Patients requiring mastoidectomy had infections that were already severe prior 
to the surgery. Th e overall outcomes across all patient groups in our study are similar to those 
reported in prior literature (Osma et al. 2000, Sennaroglu et al. 2000, Penido et al. 2005, Dubey 
et al. 2010, Groth et al. 2012). In our material, the outcome of children was better than that of 
adults, probably because children have less chronic ear infections. 
Since the acute infections of patients with CSOM may lead to serious complications (AMc, oIAs), 
they must be effi  ciently treated. In patients with complicated CSOM, the common pathogens are 
Ps, Sa, and Gram-negative enteric bacteria. Patients who have already developed chronic OM 
should be effi  ciently treated and followed. Antimicrobial treatment of complicated chronic OM 
should effi  ciently cover the most common bacterial pathogens of CSOM (Ps, Sa, and Gram-
negative enteric bacteria). 
Th e treatment of oIAs was not specifi cally analyzed in this thesis. Most patients with IAs in this 
study received antimicrobial treatment, the only exception were patients arriving at the hospital 
in critical condition, dying before treatment was possible. Almost all patients (99%) with IAs 
underwent surgery for their abscess. At our institution, the underlying (ear) infection is treated 
when the patients are stable, usually aft er the initial treatment of the IA.  
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Future perspec? ves 
PCVs were added to our national immunization protocol in September 2010 and our data 
collection period ended in 2012. Our aim, however, was not to evaluate the eff ect of PCVs on 
OM complications. Although PCVs are eff ective against invasive pneumococcal disease, against 
AOM caused by Pnc, and have resulted in a reduction in tympanostomies among children, they 
seem not to have resulted in a reduced incidence of AM (Eskola et al. 2001, Poehling et al. 2007, 
Sarasoja et al. 2013, Whitney et al. 2003, Palmu et al. 2013). Pnc replacement by non-vaccine 
serotypes has been reported, some of these serotypes are virulent and have a tendency to develop 
antimicrobial resistance (Casey et al. 2010, Hoberman et al. 2011b). Multivalent PCVs are 
available, however, and may, in the future, change the prevention landscape. Th e eff ect of PCVs 
on the development of AOM complications is important to monitor in the future.
Anatomical conditions may exist that predispose a person to developing complications from 
OM. For example, the size of the mastoid might aff ect development of mastoid infections; this 
too warrants further study. Genetic susceptibility for the development of complicated OM is also 
an interesting issue for future research, as well as the use of steroids in the treatment of OM 
complications.  
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7 CONCLUSION
Acute complications of OM are rare in Finland compared with other European countries. 
However, their incidence has risen over the last decade.  
1. Th e clinical fi ndings in children with AM diff er depending on the causative pathogen. Pnc, 
particularly the resistant strains, oft en cause severe symptoms and lead to mastoidectomy. 
Ps typically causes milder symptoms and aff ects mainly older children with prior 
tympanostomy tubes. 
2. Children hospitalized due to AOM or AM have a diff erent bacteriological etiology than 
those with outpatient AOM. Th e typical AOM pathogens, Hi and Mc, were uncommon 
in the complicated (hospitalized) patients. Pnc, especially its resistant strains, was less 
common among patients hospitalized due to AOM than AM. Children with AOM required 
less surgical interventions and had a shorter hospitalization period than those with AM. 
StrA and Ps were linked to otorrhea and were only found in older children. 
3. Otogenic IAs have become less common over time and are usually due to CSOM, oft en in 
connection with cholesteatoma. 
  
4. In adults, the bacteriological etiology of hospitalized AOM, AM, and LM (Pnc, StrA, and 
Ps) diff ers from that of AMc (Ps, Sa, and Gram-negative enteric bacteria). LM and AMc 
lead to more surgical procedures than do the acute complications of AOM or AM. 
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